微创颅内血肿清除术治疗高血压脑出血患者的疗效及安全性分析  

Efficacy and Safety of Minimally Invasive Intracranial Hematoma Removal in Patients with Hypertensive Cerebral Hemorrhage

作　　者：刘春[1] LIU Chun(Department of Neurosurgery,People's Hospital of Lianshui County,Lianshui,Jiangsu Province,223400 China)

机构地区：[1]江苏省淮安市涟水县人民医院神经外科,江苏涟水223400

出　　处：《中外医疗》2020年第8期13-15,共3页China & Foreign Medical Treatment

摘　　要：目的分析高血压脑出血患者采取微创颅内血肿清除术治疗的效果及安全性。方法该次研究方便选择2014年1月-2019年8月该院收治高血压脑出血患者50例作为观察对象,根据入院时间先后分为观察组与对照组,对照组患者采取保守治疗,观察组患者采取微创颅内血肿清除术治疗,比较治疗效果。记录并分析各组患者治疗后炎性因子指标差异,评估并对比两组患者治疗前后神经功能缺损评分,计算各组并发症发生率。结果观察组患者治疗总效果96.67%明显优于对照组(χ~2=5.330,P<0.05)。同时,观察组患者IL-6(13.92±2.01)ng/L、TNF-α(40.05±2.44)μg/L、hsCRP(7.01±1.44)mg/L均优于对照组(t=16.160、17.630、12.960,P<0.05)。两组患者未经治疗前,神经缺损评分差异无统计学意义(P>0.05),经治疗后,观察组NIHSS(11.99±2.22)分低于对照组(t=14.520,P<0.05)。另外,观察组患者出现并发症的概率6.67%较对照组更低(χ~2=6.530,P<0.05)。结论高血压脑出血患者采取微创颅内血肿清除术治疗效果更佳,能够改善患者神经功能,减少并发症。Objective To analyze the effect and safety of minimally invasive intracranial hematoma removal in patients with hypertensive cerebral hemorrhage. Methods In this study, 50 patients with hypertensive cerebral hemorrhage treated in the hospital from January 2014 to August 2019 were convenient selected as observation objects. They were divided into observation group and control group according to the time of admission. The control group adopted conventional treatment,the observation group adopted minimally invasive intracranial hematoma removal, to compare the treatment effects. Record and analyze the differences of inflammatory factor indexes after treatment in each group of patients, evaluate and compare the neurological deficit scores before and after treatment, and calculate the incidence of complications in each group.Results The total treatment effect in the observation group was 96.67%, which was significantly better than that in the control group(χ~2= 5.330, P<0.05). At the same time, the IL-6(13.92±2.01) ng/L, TNF-α (40.05±2.44)ug/L, and hs-CRP(7.01±1.44)mg/L were better in the observation group than in the control group(t=16.160, 17.630, 12.960, P<0.05). Before treatment, there was no statistically significant difference in the neurological defect score between the two groups of patients(P>0.05). After treatment, the NIHSS in the observation group(11.99±2.22)points was lower than that in the control group(t=14.520, P<0.05). In addition, patients in the observation group 6.67% of the complications,which was lower than that of the control group (χ~2=6.530,P<0.05). Conclusion Minimally invasive intracranial hematoma removal is better in patients with hypertensive cerebral hemorrhage, which can improve patients’ neurological function and reduce complications.

关 键 词：微创颅内血肿清除术 高血压 脑出血 安全性 

分 类 号：R651[医药卫生—外科学]